InvestorsHub Logo
icon url

volgoat

06/23/14 10:47 AM

#180836 RE: biopharm #180835

“This is the tip of the iceberg,” said Robert Garry, a microbiology professor at the Tulane University School of Medicine who’s been leading relief and investigation efforts in Sierra Leone for the Viral Hemorraghic Fever Consortium.

http://www.nbcnews.com/health/health-news/ebola-outbreak-tip-iceberg-experts-say-n137081
icon url

PhoenixRising

06/23/14 11:13 AM

#180843 RE: biopharm #180835

bio, I am cognizant of what you are touting in regards to the "potential" of Bavi for many indications. But you have covered almost EVERY aspect of civilization as we know it(tic). My point,and mine only, is for PPHM to FOCUS on what they have NOW working in trials...have they not encountered enough turbulence already?To sum up,IMO, if PPHM comes out with a PR stating they're starting a trial for malaria/DS BEFORE a PR with an update in regards to enrolled patients or stats regarding Phase III I will consider PPHM a rudderless boat adrift in the big,stormy ocean of bios. FOCUS is the key for ME. GL carpe diem PR